Education
About Us
Working with TipRanks
Follow Us
Robert Gunderson Insider Profile
4 Followers
Robert Gunderson, Director at Theravance Biopharma, holds 12.63K shares in Andersen Group, Inc. Class A (Ticker: ANDG), holds 78.94K shares in Theravance Biopharma (Ticker: TBPH), holds 26.83K shares in Vitae Pharma (Ticker: VTAE). Most recently, Robert Gunderson Bought ― shares of Andersen Group, Inc. Class A on Dec 22, 2025 for an estimated value of $202.13K.
Robert Gunderson Theravance Biopharma (TBPH)Director
Theravance Biopharma (TBPH)
Director
Ranked #67,652 out of 106,131 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-15.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Gunderson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 22, 2025 - Today
Return:-12.30%
The most profitable trade made by Robert Gunderson
Robert Gunderson's Trading History
Theravance Biopharma
Apr 29, 2021
Director
Uninformative Buy
―
$1.10M
Andersen Group, Inc. Class A
Dec 22, 2025
Director
Informative Buy
202.13K
$308.50K
Vitae Pharma
Oct 25, 2016
―
Uninformative Sell
563.47K
$563.47K
Innoviva
May 27, 2014
Director
Uninformative Buy
―
$2.71M
List of latest transactions for each holding click on a transaction to see Robert Gunderson's performance on stock
You May Also Like
Robert Gunderson insider profile FAQ
What is the percentage of profitable transactions made by Robert Gunderson?
The percentage of profitable transactions made by Robert Gunderson is 0%.
What is the average return per transaction made by Robert Gunderson?
The average return per transaction made by Robert Gunderson is -15.70%.
What stocks does Robert Gunderson hold?
Robert Gunderson holds: TBPH, ANDG, VTAE, INVA stocks.
What was Robert Gunderson’s latest transaction?
Robert Gunderson latest transaction was an Informative Buy of $202.13K.
What was Robert Gunderson's most profitable transaction?
Robert Gunderson’s most profitable transaction was an Informative Buy of ANDG stock on December 22, 2025. The return on the trade was -12.30%.
What is Robert Gunderson's role in Theravance Biopharma?
Robert Gunderson's role in Theravance Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.